Slow-release drug for the treatment of piglet pneumonia

Enzootic pneumonia of piglets caused a considerable economic damage. It includes direct losses from mortality, forced slaughter, low weight gains, loss of breeding qualities, direct emergency costs associated with frequent and often inefficient treatment of animals, disinfection, sanitary repair of rooms and others, indirect costs. The paper considers how to increase the efficiency of measures against piglet pneumonia of bacterial etiology. It discusses tylosin forms, the possibilities of prevention of toxic effects by achieving a fast and complete effect when drugs are administered in lower, than usual, daily doses, prevention or reduction of the acquired drug resistance of pathogenic microorganisms. It also highlights the questions of increasing the economic efficiency, environmental safety and economic efficiency of the drugs used.